Daily Stock Analysis, NVCN, Neovasc Inc, priceseries

Neovasc Inc. Daily Stock Analysis
Stock Information
Open
0.48
Close
0.46
High
0.48
Low
0.44
Previous Close
0.48
Daily Price Gain
-0.02
YTD High
0.63
YTD High Date
Feb 8, 2022
YTD Low
0.39
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.03
YTD Gain
-7.08%
52 Week High
1.45
52 Week High Date
Mar 15, 2021
52 Week Low
0.39
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-0.70
52 Week Gain
-60.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 13. 2017
1400.00
Mar 24. 2017
1591.40
9 Trading Days
13.67%
Link
LONG
Sep 13. 2017
1250.00
Oct 5. 2017
1658.63
16 Trading Days
32.69%
Link
LONG
May 2. 2018
45.40
May 3. 2018
48.15
1 Trading Days
6.06%
Link
LONG
May 22. 2018
36.20
May 25. 2018
38.40
3 Trading Days
6.08%
Link
LONG
Jun 20. 2018
37.30
Jul 6. 2018
41.12
11 Trading Days
10.24%
Link
LONG
Jan 15. 2019
6.19
Jan 25. 2019
6.72
7 Trading Days
8.51%
Link
LONG
Apr 17. 2019
5.40
Apr 18. 2019
6.00
1 Trading Days
11.11%
Link
LONG
Jun 14. 2019
5.13
Jun 27. 2019
5.49
9 Trading Days
7.10%
Link
LONG
Sep 6. 2019
2.95
Sep 24. 2019
3.75
12 Trading Days
27.08%
Link
LONG
Dec 18. 2019
3.27
Jan 2. 2020
4.02
9 Trading Days
22.86%
Link
LONG
Apr 8. 2020
1.54
May 12. 2020
2.54
23 Trading Days
64.69%
Link
LONG
May 19. 2020
2.58
Jun 11. 2020
3.06
16 Trading Days
18.50%
Link
LONG
Jul 7. 2020
2.45
Jul 9. 2020
2.58
2 Trading Days
5.51%
Link
LONG
Jul 16. 2020
2.41
Jul 30. 2020
2.56
10 Trading Days
6.27%
Link
LONG
Oct 7. 2020
2.21
Oct 21. 2020
2.41
10 Trading Days
8.93%
Link
LONG
Feb 2. 2021
1.29
Feb 19. 2021
1.80
12 Trading Days
39.34%
Link
Company Information
Stock Symbol
NVCN
Exchange
NasdaqCM
Company URL
http://www.neovasc.com
Company Phone
604-270-4344
CEO
Alexei J. Marko
Headquarters
British Columbia
Business Address
2135 13700 Mayfield place, RICHMOND, CANADA 00000
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001399708
About

Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

Description

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.